ED
BCR

Exane Derivatives’s CR Bard Inc. BCR Stock Holding History

Exane Derivatives’s Portfolio BCR Stock Details BCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1
Closed -$316 – 676
2017
Q2 		$316 Sell
1
-11,281
-100% -$3.35M ﹤0.01% 517
2017
Q1 		$2.8M Sell
11,282
-7,347
-39% -$1.77M 0.63% 45
2016
Q4 		$4.18M Sell
18,629
-18,016
-49% -$3.91M 0.83% 24
2016
Q3 		$8.22M Sell
36,645
-18,637
-34% -$4.19M 1.23% 21
2016
Q2 		$13M Buy
+55,282
New +$12M 2.15% 7

Other funds holding BCR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Exane Derivatives's BCR Position: Q3 2017 in Review

Exane Derivatives sold out of CR Bard Inc. (BCR) in Q3 2017, closing a stake of 1 share — an estimated $316 sold.

Exane Derivatives first reported a position in BCR in Q2 2016 and held it in 5 quarters. The position peaked at $13M in Q2 2016. 630 funds tracked by Wall St. Rank hold BCR as of Q3 2017.

  • Exane Derivatives reported no remaining CR Bard Inc. position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 1 CR Bard Inc. share in Q3 2017, an estimated $316.
  • Exane Derivatives first reported a position in CR Bard Inc. in Q2 2016 and held it in 5 quarters.
  • Exane Derivatives's CR Bard Inc. position peaked at $13M in Q2 2016.
  • 630 funds tracked by Wall St. Rank held CR Bard Inc. as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.